Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD5004 (ECC5004) | ≥99%(HPLC) | Selleck | GLP-1 Receptor 阻害剤
AZD5004
AZD5004 / Eccogene, AstraZeneca
Azd5004 – Application in Therapy and Current Clinical Research
Study on the Effects of AZD5004 and Semaglutide for Adults with Type 2 ...
Estudio sobre los efectos de AZD5004 en adultos con obesidad o ...
Estudio sobre la eficacia y seguridad de AZD5004 en adultos con ...
Structure of AZD3582. | Download Scientific Diagram
AstraZeneca’s AZD5004 Obesity Trial Edges Forward, Raising New ...
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It ...
Chemical structure of AZD | Download Scientific Diagram
Molecular structure of AZD1305. | Download Scientific Diagram
Structure of AZD2563. | Download Scientific Diagram
Elecoglipron (ECC5004/AZD5004) | GLP-1R agonist | Probechem Biochemicals
阿斯利康 三期临床分子：AZD5004 合成与供应 - 知乎
#Wikimole Compounds – Caltag Medsystems
Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and ...
百亿美元市场！领路者阿斯利康两手抓：奥拉帕利再获新适应症，下一代产品多款布局
阿斯利康的AZD5004、罗氏的CT-996与Terns的TERN-601均展现出较好的I期临床数据 - 2025年09月 - - 小牛行研
elecoglipron (AZD5004) / Eccogene, AstraZeneca
Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a ...
Non-clinical and first-in-human characterization of ECC5004/AZD5004, a ...
AstraZeneca’s AZD5004: A Power Move in Obesity Medicine
Elecoglipron | C48H46F2N10O5 | CID 169644648 - PubChem
阿斯利康：GLP-1/GCG+Amylin启动减重2b期临床
Computational Study on New Natural Compound Inhibitors of Pyruvate ...
Eccogene Receives Milestone Payment of $60 Million from AstraZeneca ...
AZ·에코진, 경구용 GLP-1 후보 ‘AZD5004’ 中 임상1b상 돌입…첫 환자 투약
ECC5004(AZD5004) GLP-1 Receptor Agonist | Selleck Chemicals
Eccogene首次在中國進行AZD5004臨床試驗 - ss future
Azidothymidine, Zidovudine, Cpd S, AZT, BW-A509U, AZTEC, Retrovir-药物合成数据库
AZ, 올해 '먹는 비만약' 임상2b상 추진…"비만보다 체중관리 초점"
4周减重九斤！阿斯利康披露口服小分子GLP-1药物的最新数据，超18亿美元合作有望兑现_腾讯新闻
Structure, biochemical, and cellular activity of AZD2014. A, chemical ...
GLP-1 小分子AZD5004/ECC5004 出现肝毒性及男女代谢差异
AZD0780 | Inhibitor | TargetMol
超18亿美元合作核心，阿斯利康口服GLP-1疗法4周减重5.8%
AZD5904 | MPO Inhibitor | Selleck Chemicals
Small-molecule Articles | Smolecule
AZD-5462 | Selleck Chemicals
LUNA18
A Study to Investigate Multiple Ascending Doses and Relative ...
Structures and atom numbering of the studied compounds, and the ...
Elecoglipron - Drug Targets, Indications, Patents - Synapse
AZD0516 | Anti-STEAP2 ADC | MedChemExpress
潜在重磅小分子GLP-1新药在华获批临床！阿斯利康超20亿美元合作开发
Schematic of AZD0466 drug substance and drug product process. A ...
AZD1656 | Carbohydrate Metabolism activator | CAS 919783-22-5 | Selleck
AZD9574 (Palacaparib) | PARP1 Inhibitor | CAS 2756333-39-6 | Selleck ...
Full article: Light responsive liquid crystal soft matters: structures ...
Obesity News Recap ~ WC (04/11/2024) 💡 🌿 SJLife Sciences 🌿 ...
Synthesis and Evaluation of 2,4-Disubstituted Quinazoline Derivatives ...
Eccogene Announces Positive Topline Results from Phase 1b Trial of ...
潜在5款重磅下一代GLP-1疗法|糖尿病|阿斯利康|临床试验_新浪新闻
Optimized structures for 4c and 4d azaindazole derivatives and their ...
AZDye488-Azide, Azide-containing Fluorescent Dyes - Jena Bioscience
Schematic representation of the AZD2 molecular structure. | Download ...
Deuterated AZ5104 | 2129998-32-7
